Introduction: Atopic dermatitis (AD) is the most common inflammatory skin disease. It has a
complex pathophysiology, with a combination of immune dysregulation and intrinsic barrier …

Atopic dermatitis (AD) is a common inflammatory skin disease characterized by intense
pruritus and recurrent eczematous lesions that significantly impair quality of life. It is a …

A major component of COVID-19 severe respiratory syndrome is the patient's immune
response to the SARS-CoV-2 virus and the consequential multi-organ inflammatory …

Atopic dermatitis (AD) is a heterogeneous disease with unique clinical manifestations across
age groups and race/ethnicities. Characteristic molecular mechanisms, known as …

Key research advances in atopic dermatitis (AD) suggest the complexity of its endotypes. A
comprehensive serum biomarker panel revealed at least 4 types of AD. Some represent …

Background Although there is increased understanding of the alopecia areata (AA)
pathogenesis based on studies in scalp tissues, little is known about its systemic profile …

Atopic dermatitis imposes a significant burden on patients, families and healthcare systems.
Management is difficult, due to disease heterogeneity, co‐morbidities, complexity in care …

Background RPT193 is an orally administered small molecule antagonist of the human C‐C
motif chemokine receptor 4 (CCR4) that inhibits the migration and downstream activation of …

Background In atopic dermatitis (AD), some studies have shown an association with
increased cardiovascular disease in certain populations. However, other investigations …

Atopic dermatitis (AD) is a highly prevalent inflammatory skin disease that affects nearly 10%
of adults worldwide. 1 AD is heterogeneous, predominated by TH2/TH22 activation with …